iPSC Transplantation increases regeneration and functional recovery after ischemic stroke in neonatal rats

Monica J Chau1, Todd C Deveau, Mingke Song

  • 1Department of Anesthesiology, Emory University School of Medicine, Atlanta, Georgia, USA.

Insights

Transplanted induced pluripotent stem cell-derived neural progenitor cells (iPSC-NPCs) promote regeneration and functional recovery in neonatal stroke models. This therapy increases beneficial trophic factors, angiogenesis, and neurogenesis, offering new hope for stroke treatment.

Area of Science:

  • Regenerative Medicine
  • Neuroscience
  • Stem Cell Biology

Background:

  • Perinatal and neonatal stroke have limited treatment options.
  • Induced pluripotent stem cells (iPSCs) show therapeutic potential for stroke.
  • The efficacy of iPSC transplantation in neonates remains largely unexplored.

Purpose of the Study:

  • To investigate the therapeutic potential of iPSC-derived neural progenitor cells (iPSC-NPCs) in a neonatal rat stroke model.
  • To determine if iPSC-NPC transplantation enhances regeneration and functional recovery after stroke.

Main Methods:

  • Mouse iPSCs were differentiated into iPSC-NPCs.
  • Ischemic stroke was induced in P7 rats; iPSC-NPCs were transplanted 7 days post-stroke.
  • Trophic factors, cell survival, neurogenesis, angiogenesis, and functional recovery were assessed.

Main Results:

  • Transplanted iPSC-NPCs expressed mature neuronal markers and functional channels.
  • iPSC-NPC transplantation increased peri-infarct expression of SDF-1α and VEGF.
  • Transplanted cells integrated and survived, promoting neurogenesis and angiogenesis.
  • Animals receiving iPSC-NPCs showed improved sensorimotor function.

Conclusions:

  • iPSC-NPC therapy offers a promising regenerative approach for neonatal stroke.
  • Therapeutic effects include trophic factor support, enhanced angiogenesis and neurogenesis, and tissue repair.
  • This study supports the potential of iPSC-NPCs for treating neonatal stroke.